Leaders in Pharmaceutical Business Intelligence (LPBI) Group

About: Aviva Lev-Ari, PhD, RN

Website

http://pharmaceuticalintelligence.wordpress.com

Details

Founder & Director of Leaders in Pharmaceutical Business Intelligence (LPBI) Venture Value Creator @LPBI: VENTURE #1: e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical Open Access Online Scientific Journal http://pharmaceuticalintelligence.com VENTURE #2: BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine http://pharmaceuticalintelligence.com/biomed-e-books/ VENTURE #3: International Scientific Delegations http://pharmaceuticalintelligence.com/scientific-delegation VENTURE #4: Funding, Deals & Partnerships http://pharmaceuticalintelligence.com/joint-ventures/ Corporate Clients for our Services Funding Cardiovascular Medical Devices Development Funding Biologics Development Funding Diagnostics Funding Partnerships in IP Development M&A and Exit Targeting Penetration in New Markets for High Technology Products Management of Engineering Design of Prototypes Outsourcing VENTURE #5: IP Invented HERE! VENTURE # 6: PRESS Coverage of Conferences http://pharmaceuticalintelligence.com/press-coverage/ - University of California, Berkeley, PhD '83 - Stanford University - GSB Exchange Program, 1980/81 - Northeastern University, Biological Sciences & Nursing '07 Worked at Director level with Start-ups and Fortune 100 companies making presentations at the CEO Board Room level. Start ups: TimeØ Group, Concept Five Technologies, Inc., MDSS, Inc.; Top Tier Management Consulting: SRI International, Monitor Group; OEM: Amdahl Corporation; Top 6th System Integrator: Perot System Corporation; FFRDC: MITRE Corporation. In the Publishing industry: McGraw-Hill/CTB. Researcher on Cardiovascular Pharmaco-therapy at Bouve College of Health Sciences, Northeastern University.

Posts by Aviva Lev-Ari, PhD, RN:

• August 27, 2023 ChatGPT Chemistry Assistant for Text Mining and the Prediction of metal–organic framework (MOF) synthesis

• August 19, 2023 Eight Subcellular Pathologies driving Chronic Metabolic Diseases – Methods for Mapping Bioelectronic Adjustable Measurements as potential new Therapeutics: Impact on Pharmaceuticals in Use

• June 25, 2023 World Medical Innovation Forum, June 12 – June 14, 2023 The Westin Boston Seaport District organized by Mass General Brigham (MGB)

• June 14, 2023 Optimism for Future Equality of Access to Healthcare in the Inaugural address as AMA President, Jesse M. Ehrenfeld, MD, MPH | AMA 2023 Annual Meeting of House of Delegates

• June 10, 2023 Health Care Policy Analysis derived from the Farewell remarks from AMA President Jack Resneck Jr., MD | AMA 2023 Annual Meeting

• June 9, 2023 W. Gerald “Jerry” Austen, MD influential in the design and creation of a cardiopulmonary (heart-lung) bypass machine and the intra-aortic balloon pump at MGH as renowned cardiac surgeon

• May 24, 2023 Testimonial on the English to Spanish Translation JOINT Project that yielded the “BioMed e-Series Spanish-language Edition” on Amazon.com

• May 5, 2023 percutaneous Left Ventricular Assist Device (pLVAD) – An Israeli startup, Magenta Medical, behind the world’s smallest heart pump has raised $55 million

• May 3, 2023 microRNA (miRNA) miR-483-5p has a key role in preventing stress-related anxiety by acting on its target gene Pgap2 that curbs the development of this type of anxiety

• March 7, 2023 Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes

Older Posts »